Appeal No. 2004-1112 Page 5 Application No. 09/829,707 public, and therefore not available as prior art under 35 U.S.C. § 102(a), until it issued as a patent. Since Rosner did not issue until after the filing date of the instant application, it does not qualify as prior art under § 102(a). The correct statute for applying a patent that was filed before, but issued after, a given application filing date is 35 U.S.C. § 102(e). See In re Lund, 376 F.2d 982, 988, 153 USPQ 625, 630 (CCPA 1967) (“It is, of course, incontrovertible that a description of an invention of another in an application filed before an applicant's date of invention, upon which application a patent is issued, constitutes a bar to the issuance of a valid patent for the same invention, Alexander Milburn Co. v. Davis-Bournonville Co., 270 U.S. 390, 46 S.Ct. 324, 70 L.Ed. 651 (1926), codified by § 102(e).”). See also id. at 992 n.12, 153 USPQ 625, 633 n.12 (“Inasmuch as § 102(e) makes a description in a patent available as evidence of prior knowledge as of the effective filing date of the application on which the patent issues, it should be regarded as an exception to the general rule that prior knowledge must be public in order to defeat another’s patent rights.”). 2. Bremer The examiner rejected claims 15-27 as anticipated by Bremer, on the basis that Bremer “discloses glucosidase and/or amylase inhibitors that can be manufactured as pharmaceutical compositions for the combined use with a lipase inhibitor.” Examiner’s Answer, pages 4-5. The examiner pointed out that Bremer suggests acarbose as one of the inhibitors that can be included in the disclosed compositions, and concluded that the “pharmaceutical composition thatPage: Previous 1 2 3 4 5 6 7 8 9 10 11 12 NextLast modified: November 3, 2007